Evidence map›Paper›PMID 31614495›Full record

ArticleMaterials (Basel, Switzerland)2019

Simple In-House Fabrication of Microwells for Generating Uniform Hepatic Multicellular Cancer Aggregates and Discovering Novel Therapeutics.

Chiao-Yi Chiu, Ying-Chi Chen, Kuang-Wei Wu, Wen-Chien Hsu, Hong-Ping Lin, Hsien-Chang Chang, Yung-Chun Lee, Yang-Kao Wang, Ting-Yuan Tu

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Chiao-Yi ChiuDepartment of Biomedical Engineering, National Cheng Kung University, Tainan 70101, Taiwan.
Ying-Chi ChenDepartment of Biomedical Engineering, National Cheng Kung University, Tainan 70101, Taiwan. yingtzai@gmail.com.
Kuang-Wei WuDepartment of Biomedical Engineering, National Cheng Kung University, Tainan 70101, Taiwan. stephen0001345@gmail.com.
Wen-Chien HsuDepartment of Biomedical Engineering, National Cheng Kung University, Tainan 70101, Taiwan. d2532875@gmail.com.
Hong-Ping LinDepartment of Chemistry, National Cheng Kung University, Tainan 70101, Taiwan. hplin@mail.ncku.edu.tw.
Hsien-Chang ChangDepartment of Biomedical Engineering, National Cheng Kung University, Tainan 70101, Taiwan.
Yung-Chun LeeCenter for Micro/Nano Technology Research, National Cheng Kung University, Tainan 70101, Taiwan. yunglee@mail.ncku.edu.tw.ORCID 0000-0001-8990-6615
Yang-Kao WangDepartment of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan. humwang@mail.ncku.edu.tw.
Ting-Yuan TuDepartment of Biomedical Engineering, National Cheng Kung University, Tainan 70101, Taiwan. tingyuan@mail.ncku.edu.tw.ORCID 0000-0002-1816-4615
National Cheng Kung University · TW

Funding

Ministry of Science and Technology, Taiwan MOST 106-2218-E-006-009-Ministry of Science and Technology, Taiwan MOST 108-2636-B-006-003-
6 · The paper itself

Abstract

Three-dimensional (3D) cell culture models have become powerful tools because they better simulate the in vivo pathophysiological microenvironment than traditional two-dimensional (2D) monolayer cultures. Tumor cells cultured in a 3D system as multicellular cancer aggregates (MCAs) recapitulate several critical in vivo characteristics that enable the study of biological functions and drug discovery. The microwell, in particular, has emerged as a revolutionary technology in the generation of MCAs as it provides geometrically defined microstructures for culturing size-controlled MCAs amenable for various downstream functional assays. This paper presents a simple and economical microwell fabrication methodology that can be conveniently incorporated into a conventional laboratory setting and used for the discovery of therapeutic interventions for liver cancer. The microwells were 400-700 µm in diameter, and hepatic MCAs (Huh-7 cells) were cultured in them for up to 5 days, over which time they grew to 250-520 µm with good viability and shape. The integrability of the microwell fabrication with a high-throughput workflow was demonstrated using a standard 96-well plate for proof-of-concept drug screening. The IC

Indexed as

doxorubicinliver cancermicrowellmulticellular cancer aggregatesmulticellular tumor spheroidsphotothermal treatment

Identifiers

PMID31614495
PMCPMC6829256
OpenAlexW2979812438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.